MBX
MBX Biosciences, Inc.
57.72
+1.39 (+2.47%)
52w low 23.07
72.64 high
69.9% of range
Financial Analysis
| (USD) | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|
| Cash & Equivalents | 24.21M | 30.52M | 49.35M | 75.29M | |
| Receivables | 142.00K | 208.00K | 682.00K | 2.12M | |
| Current Assets | 44.21M | 83.47M | 267.29M | 381.54M | |
| Net PP&E | 842.00K | 665.00K | 1.20M | 3.22M | |
| Total Assets | 45.09M | 84.18M | 268.54M | 385.14M | |
| Current Liabilities | 3.43M | 3.93M | 11.05M | 15.49M | |
| Total Debt | 461.00K | 324.00K | 171.00K | 596.00K | |
| Total Liabilities | 87.70M | 156.65M | 11.09M | 15.92M | |
| Retained Earnings | -43.02M | -75.58M | -137.50M | -224.48M | |
| Shareholders Equity | -42.60M | -72.47M | 257.44M | 369.22M | |
| Working Capital | 40.78M | 79.54M | 256.24M | 366.04M | |
| Shares Outstanding | 31.85M | 31.85M | 33.42M | 44.93M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--